Specific group II metabotropic glutamate receptor activation inhibits the development of kindled epilepsy in rats
Specific group II metabotropic glutamate receptor activation inhibits the development of kindled epilepsy in rats
复制标题
DOI:
10.1016/s0006-8993(97)01500-x
复制
发表时间:
1998-03-23
期刊:
影响因子:
2.9
通讯作者:
Bradford, HF
中科院分区:
文献类型:
--
作者:
Attwell, PJE;Koumentaki, A;Bradford, HF
The effects of intracerebral administration of the group II metabotropic glutamate receptor agonist, 2R,4R-APDC, were tested on both the development of amygdaloid kindling and on fully developed stage 5 amygdala kindled seizures. The development of amygdaloid kindling was significantly retarded in 2R,4R-APDC (10 nmol in 0.5 mu l) treated animals compared to control animals over a period of 8 days. At a low dose, 2R,4R-APDC (0.1 nmol) caused a 42.5 +/- 26.6% increase of the generalised seizure threshold in fully kindled animals. As higher doses were administered, however, the changes in generalised seizure threshold were less marked, and even a small decrease in the threshold was seen (-19.6 +/- 5.36% at 10 nmol). The agonist 2R,4R-APDC inhibited depolarization-induced release of [H-3]D-aspartate from cortical synaptosomes with an IC50 value of 0.29 mu M. This effect was maximal at 1 mu M, and decreased with dose thereafter. These findings suggest that the selective activation of the group II metabotropic glutamate receptors by agonists such as 2R,4R-APDC may be of therapeutic potential in the treatment of seizure disorders. (C) 1998 Elsevier Science B.V.